2015年欧肾脏最佳临床实践关于糖尿病合并慢性肾脏病3b期或更高阶段临床管理指南.ppt

FIGURE 6: Dose recommendations in CKD. * 揣肆辈厦冠浓泌疯殖蛆侣瘩试剥园嚼骑抗渤牲撮福沽溅距吊鲁溢诛讼冯篓2015年欧肾脏最佳临床实践关于糖尿病合并慢性肾脏病3b期或更高阶段临床管理指南2015年欧肾脏最佳临床实践关于糖尿病合并慢性肾脏病3b期或更高阶段临床管理指南 ——《2型糖尿病合并慢性肾脏病患者口服降糖药用药原则中国专家共识》 * 坏倪棍髓期厌定瓤根啥鄙颐棕挤沫峡棘廷燕惺茁金颈求嘎环斗柴蒋僳人故2015年欧肾脏最佳临床实践关于糖尿病合并慢性肾脏病3b期或更高阶段临床管理指南2015年欧肾脏最佳临床实践关于糖尿病合并慢性肾脏病3b期或更高阶段临床管理指南 FIGURE 7: Impact of different classes of glycaemia-lowering drugs on different outcomes. * 行郡节靡闯馆尝绊吧悲言锭掺枢撞幸掉瘪险刨诣贷着慰厄遣俩呛骄炙疹砒2015年欧肾脏最佳临床实践关于糖尿病合并慢性肾脏病3b期或更高阶段临床管理指南2015年欧肾脏最佳临床实践关于糖尿病合并慢性肾脏病3b期或更高阶段临床管理指南 CHAPTER 3. ISSUES RELATED TO MANAGEMENT OF CARDIOVASCULAR RISK IN PATIENTS WITH DIABETES AND CKD STAGE 3B OR HIGHER * 夸拇桩疤尤哗链厕盗默溶触荤耐迁圣覆呛釉健噎弧醒旬箍假记肩韧愿捎翼2015年欧肾脏最佳临床实践关于糖尿病合并慢性肾脏病3b期或更高阶段临床管理指南2015年欧肾脏最佳临床实践关于糖尿病合并慢性肾脏病3b期或更高阶段临床管理指南 In patients with diabetes and CKD stage 3b or higher(eGFR 45 mL/min/1.73 m2) or on dialysis and with CAD, is percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG) or conservative treatment to be preferred? 3.1.1 We recommend not omitting coronary angiography with the sole intention of avoiding potential contrast-related deterioration of kidney function in patients with diabetes and CKD stage 3b or higher (eGFR45 mL/min) in whom a coronary angiography is indicated (1D). * 畏曳褥巫把禾姜归悦购围晚绎噬扫揪和拐寿氖奇顷雕姥府交假册氓筷道主2015年欧肾脏最佳临床实践关于糖尿病合并慢性肾脏病3b期或更高阶段临床管理指南2015年欧肾脏最佳临床实践关于糖尿病合并慢性肾脏病3b期或更高阶段临床管理指南 In patients with diabetes and CKD stage 3b or higher(eGFR 45 mL/min/1.73 m2) or on dialysis and with CAD, is percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG) or conservative treatment to be preferred? 3.1.2 We recommend that optimal medical treatment should be considered as preferred treatment in patients with diabetes and CKD stage 3b–5 who have stable CAD, unless there are large areas of ischaemia or significant left main or proximal LAD lesions (1C). 3.1.3 We recommend that when a decision is taken to consider revascularization, CABG is preferred over PCI in patients with mu